Product Information

BUPROPION HCL SR 150 MG TABLET is a generic product labeled by ScieGen Pharmaceuticals, Inc., priced at $0.0840 per EA under NDC 50228017560. Its NADAC has been published 307 times since Aug 12, 2020.

BUPROPION HCL SR 150 MG TABLET

bupropion hydrochloride
$0.0840per EA

Strength

150 mg/1

NDC

50228017560

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

BUPROPION HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA205794

On Market Since

4/20/2018

Pharmacological Classes

Aminoketone
Dopamine Uptake Inhibitors
Increased Dopamine Activity
Increased Norepinephrine Activity
Norepinephrine Uptake Inhibitors

Price Statistics

The NADAC for BUPROPION HCL SR 150 MG TABLET has been published 307 times since Aug 12, 2020, and over the history we have for it it has declined 29.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0840 per EA
All-time high$0.1199 (Aug 12, 2020)
All-time low$0.0709 (May 22, 2024)
52-week high$0.0863
52-week low$0.0805
Median price$0.0878
Average price$0.0931
Largest weekly change+20.0% (Jun 19, 2024)
Weeks tracked307
Tracking sinceAug 12, 2020

Price History

1W

0.0%

1M

+0.4%

3M

+2.5%

6M

+2.2%

1Y

-2.7%

3Y

-4.3%

5Y

-27.2%

All

-29.9%

Generic Alternatives

The matcher finds 14 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of BUPROPION HCL SR 150 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for BUPROPION HCL SR 150 MG TABLET, manufactured by ScieGen Pharmaceuticals, Inc., is $0.0840 per EA (NDC 50228017560), effective Jun 24, 2026.

How has the price of BUPROPION HCL SR 150 MG TABLET changed over time?

Over the history we have for it, the NADAC for BUPROPION HCL SR 150 MG TABLET has declined 29.9%. It has been tracked across 307 weekly CMS publications since Aug 12, 2020.

What are the highest and lowest recorded NADAC prices for BUPROPION HCL SR 150 MG TABLET?

Since Aug 12, 2020, the NADAC for BUPROPION HCL SR 150 MG TABLET has ranged from a low of $0.0709 (May 22, 2024) to a high of $0.1199 (Aug 12, 2020), with a median of $0.0878 per EA.

Are there cheaper alternatives to BUPROPION HCL SR 150 MG TABLET?

Yes. 14 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, BUPROPION HCL XL 150 MG TABLET, is $0.0779 per EA — about 7% below BUPROPION HCL SR 150 MG TABLET.

Who manufactures BUPROPION HCL SR 150 MG TABLET?

BUPROPION HCL SR 150 MG TABLET (NDC 50228017560) is labeled by ScieGen Pharmaceuticals, Inc., and CMS classifies it as a generic product.